176 related articles for article (PubMed ID: 29524189)
1. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.
Haluzik M; Kretowski A; Strojek K; Czupryniak L; Janez A; Kempler P; Andel M; Tankova T; Boyanov M; Smircic Duvnjak L; Madacsy L; Tarnowska I; Zychma M; Lalic N
Diabetes Ther; 2018 Apr; 9(2):727-741. PubMed ID: 29524189
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study.
Hussein Z; Kamaruddin NA; Chan SP; Jain A; Uppal S; Bebakar WMW;
Diabetes Res Clin Pract; 2017 Nov; 133():40-49. PubMed ID: 28888148
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil.
Lamounier RN; Geloneze B; Leite SO; Montenegro R; Zajdenverg L; Fernandes M; de Oliveira Griciunas F; Ermetice MN; Chacra AR;
Diabetol Metab Syndr; 2018; 10():83. PubMed ID: 30479669
[TBL] [Abstract][Full Text] [Related]
4. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study.
Emral R; Tetiker T; Sahin I; Sari R; Kaya A; Yetkin İ; Cil SU; Tütüncü NB;
BMC Endocr Disord; 2018 Feb; 18(1):9. PubMed ID: 29433560
[TBL] [Abstract][Full Text] [Related]
5. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
[TBL] [Abstract][Full Text] [Related]
6. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
7. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
Geelhoed-Duijvestijn PH; Pedersen-Bjergaard U; Weitgasser R; Lahtela J; Jensen MM; Östenson CG
J Med Econ; 2013 Dec; 16(12):1453-61. PubMed ID: 24144009
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.
Morales C; de Luis D; de Arellano AR; Ferrario MG; Lizán L
Diabetes Ther; 2015 Dec; 6(4):593-610. PubMed ID: 26589521
[TBL] [Abstract][Full Text] [Related]
9. Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippine Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study.
Mirasol R; Nicodemus N; Jain A; Gadekar AV; Yu-Gan S
J ASEAN Fed Endocr Soc; 2018; 33(1):12-21. PubMed ID: 33442106
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
[TBL] [Abstract][Full Text] [Related]
11. Direct Health-Care Costs and Productivity Costs Associated With Hypoglycemia in Adults With Type 1 and Type 2 Diabetes Mellitus That Participated in the Canadian Hypoglycemia Assessment Tool Program.
O'Reilly DJ; Burke N; Tarride JE; Hahn J; Nurkanovic L
Can J Diabetes; 2018 Dec; 42(6):659-663. PubMed ID: 29885881
[TBL] [Abstract][Full Text] [Related]
12. The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
Parekh W; Streeton SE; Baker-Knight J; Montagnoli R; Nicoziani P; Marchesini G
Diabetes Ther; 2018 Jun; 9(3):1037-1047. PubMed ID: 29600505
[TBL] [Abstract][Full Text] [Related]
13. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
[TBL] [Abstract][Full Text] [Related]
15. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
[TBL] [Abstract][Full Text] [Related]
17. Individual and societal consequences of hypoglycemia: A cross-sectional survey.
Dømgaard M; Bagger M; Rhee NA; Burton CM; Thorsteinsson B
Postgrad Med; 2015 Jun; 127(5):438-45. PubMed ID: 25971530
[TBL] [Abstract][Full Text] [Related]
18. The Incidence of Hypoglycemia among Insulin-Treated Patients with Type 1 or Type 2 Diabetes: Bangladeshi Cohort of International Operations-Hypoglycemia Assessment Tool Study.
Pathan MF; Fariduddin M; Nazimuddin K; Mollah AS; Islam Siddiqui MN; Hassan KA; Ferdous HS; Rahman MH; Ashrafuzzaman SM; Sobhan MJ; E-Tanvir Haider MR; Amin MF
Indian J Endocrinol Metab; 2018; 22(3):379-386. PubMed ID: 30090731
[TBL] [Abstract][Full Text] [Related]
19. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
